Coronary Artery Vasospasm


Article Author:
Supreeya Swarup


Article Editor:
Shamai Grossman


Editors In Chief:
Kranthi Sitammagari
Mayank Singhal


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Beenish Sohail
Nazia Sadiq
Hajira Basit
Phillip Hynes


Updated:
1/31/2019 12:19:40 PM

Introduction

Coronary artery vasospasm (CAVS) is a constriction of the coronary arteries that can cause complete or near-complete occlusion of the vessel. In 1959, Dr. Myron Prinzmetal described a different entity of angina than the classic Heberden's angina which was originally described in 1772. This vasospastic disease can cause acute ischemia and present anywhere along the spectrum of angina from stable angina to acute coronary syndrome. CAVS appears to be a heterogeneous disease but does not follow the traditional risk factors in the development of coronary artery disease.[1][2][3][4]

Etiology

The development of CAVS is multifactorial and can be influenced by the autonomic nervous system, inflammation, oxidative stress, endothelial dysfunction, smooth muscle cell hypercontractility, genetic predisposition, and lifestyle choices. Prinzmetal et al. published their study in 1959, which was conducted on 25 dogs where they noticed the changes that took place by occluding and releasing a large epicardial artery. They found clinical symptoms of pain and angina, electrocardiographic changes consistent with ischemia in the corresponding region, and systolic ballooning of the ischemic region. They postulated this as the course of a vasospastic epicardial coronary artery.[5][6][7][8]

Epidemiology

The prevalence of CAVS is highest between the ages of 40 and 70 and tends to decrease after 70 years. The distribution is varied throughout the world, with the highest incidence noted in Japanese population when compared to the western population. Furthermore, the frequency of multiple spasms noted on provocative testing is also higher in the Japanese population (23%) than those in Caucasians (7.5%). A German study found that every fourth patient with suspected obstructive coronary artery disease (CAD) had no culprit lesion, of these tested with acetylcholine, 50% were confirmed to be due to CAVS.

Pathophysiology

The pathogenesis of CAVS remains to be multifactorial. Originally the autonomic nervous system was thought to play an important role in the development of CAVS. However, later endothelial dysfunction, oxidative stress load, magnesium deficiency, and respiratory alkalosis were also elucidated to contribute to the pathogenesis. Most recently, genetic mutations have also been discovered which may play a role. Nevertheless, coronary vessels smooth muscle hypertonicity and reactivity play a pivotal role in the development of CAVS.

  • Autonomic Nervous System: An increase in both the parasympathetic and sympathetic activity had found to play a role in inducing CAVS. CAVS usually occurs during the night when the parasympathetic nervous system is activated. Also, acetylcholine has shown to induce CAVS, which supports the notion that parasympathetic activity can induce CAVS. However, studies have shown CAVS at night frequently occurs during rapid eye movement when there is a reduction in vagal tone with a surge in adrenergic activity. Furthermore, clinical studies have also shown that elevated catecholamine levels can also induce CAVS. Thus, the autonomic nervous system relationship with CAVS is complex and something that is still being investigated.
  • Endothelial Dysfunction: Dysfunctional endothelial nitric oxide (NO) synthase and thus decreased the release of NO have been associated with the development of CAVS. Acetylcholine, serotonin, and histamine induce endothelium-dependent vasodilatation by releasing NO from normal endothelium, however, in the presence of endothelial dysfunction they can provoke CAVS. However, endothelial dysfunction is not always seen in patients with CAVS. Thus, other factors are likely associated with manifesting CAVS.
  • Oxidative Stress: Oxidative stress is known to have a detrimental effect on vascular wall health. The reactive oxygen species (ROS) cause inflammation, endothelial damage, and vasoconstriction. Thus increased levels of ROS lead to vascular dysfunction and remodeling. Smoking has shown to reduce acetylcholine-endothelium-dependent relaxation, which means NO can be destroyed by ROS. However, the role of this relationship in the development of CAVS is complex as not all patients with CAVS have endothelial NO deficiency or dysfunction.
  • Smooth muscle cell hypercontractility: Shimokawa et al. discovered that enhanced myosin light-chain phosphorylation plays a central role in CAVS.  They further elucidated hydroxyfasudil-sensitive Rho-kinase-mediated pathway may be responsible for the enhanced myosin light-chain phosphorylation. Thus, a Rho-kinase inhibitor can potentially inhibit vasospastic activity. Further studies have shown other pathways, which may impact CAVS such as in K mutant or SUR2 K knockout mice. Loss of function of K channels has shown to cause smooth muscle cell hypercontraction in the absence of atherosclerotic disease. These studies have opened pathways to understand the implication of smooth muscle hypercontractility in developing CAVS in humans.
  • Genetics: No direct genetic link has been uncovered to date linking CAVS to genetic polymorphism. However, mutations or polymorphisms in the endothelial NO synthase gene and paraoxonase I gene have been seen in patients with CAVS. Other genetic mutations in adrenergic and serotoninergic receptors, angiotensin-converting enzyme, and inflammatory cytokines have also been described. However, the direct genetic link has yet to be discovered in all CAVS cases.

Histopathology

Increased inflammation has been associated with CAVS. Inflammation in CAVS histologically can present with infiltration of inflammatory cells such as mast cells. Mast cells have been reported at the site of CAVS, in the adventitia, and in the plaque of coronary arteries in patients with CAVS.

History and Physical

About 20 % to 30% of those complaining of chest pain who are evaluated for obstructive coronary artery disease with a coronary angiogram have normal coronary arteries. These patients may or may not present with symptoms. If symptoms are present, they may include typical anginal complaints during the episodes of vasospasm. CAVS induced pain can appear at rest and particularly between night and early morning and can be accompanied by low exercise tolerance, especially in the morning.  A patient can describe this pain as crushing, substernal chest pain with features such as radiation to the jaw or arm, and pain relieved by sublingual nitroglycerin. The physical examination should consist of a thorough cardiovascular exam, beginning with noting the vitals and ensuring hemodynamic stability and then auscultating for the heart sounds. Physicians should pay attention to the rhythm, rate, murmurs, and extra heart sounds such as S3 or S4, as well as the pulmonary exam particularly paying attention to the development of crackles which could indicate pulmonary edema.

Evaluation

An electrocardiogram (ECG) should be recorded during the episode.  Changes that can be seen are ST-elevation corresponding to the occlusion of the culprit lesion with ST depression in the contralateral leads. A diagnosis can be made if the patient is given a fast-acting nitrate during the episode and ECG findings resolve. In some cases, only ST depression can be seen in the contiguous leads. Other findings on ECG may include the development of negative T waves in the culprit lesion territory during recovery from ischemia and development of negative U waves during an active spasm.

Blood can also be checked for the release of cardiac biomarkers including Troponin I or C and creatinine kinase. However, these biomarkers are not always elevated in patients with CAVS induced chest pain.

Treatment / Management

Medical therapy with risk factor modification is the cornerstone of treatment and management of this patient population. Treatment initially consists of administering nitrates usually in the form of sublingual nitroglycerin. Nitrates cause relaxation of vascular muscle by activating the guanylate cyclase to increase the production of cGMP. CAVS should also be treated with calcium channel blockers that lower the calcium intake into the vascular smooth muscle.

Usually, CAVS can be relieved by vasodilatation. However, there are instances when the vasospastic disease is resistant to drug therapy including long-acting medications. This scenario is met in approximately 20% of the patients with CAVS. In these cases, percutaneous balloon angioplasty has not lead to favorable results. Percutaneous coronary intervention has also been studied with the continuation of medications as long-term. However, some of these patients return to vasospasm in another location. Thus, coronary stenting with long-term medical therapy should only be considered in patients who have significant stenosis from CAVS.

The application of implantable cardioverter defibrillators in patients with CAVS who present with ventricular tachycardia or ventricular fibrillation remains unknown. However, there have been reports of favorable outcomes in implanting the device in patients who survive fatal ventricular arrhythmias due to CAVS.[9][10]

Differential Diagnosis

Due to the heterogeneous presentation of CAVS, it can initially be mistaken for multiple other cardiac pathologies. CAVS may or may not present with chest pain, ECG changes, and elevated cardiac biomarkers. Thus, obstructive atherosclerotic coronary artery disease, pericarditis or myopericarditis, primary arrhythmias, and stress-induced cardiomyopathy, should always be on the differential.

Coronary angiography with provocative testing is the only definite test that can confirm CAVS disease.  Provoked CAVS is defined as luminal narrowing of 50%, 70%, 75%, or 90% with accompanying symptoms and/or ECG changes. This is then followed by intracoronary administration of nitroglycerin to dissipate the vasospastic changes on the vessel. Currently, in the United States, methylergonovine (a form of ergonovine) and acetylcholine are used in provocative testing that causes vasoconstriction in coronary arteries that have endothelial dysfunction.

Prognosis

Recurrent episodes of angina are usually seen in 4% to 19% of the patients. Advanced age and impaired left ventricular function have been identified as factors for poor prognosis in patients who present with acute coronary syndrome due to CAVS. In addition, elevated hs-CRP levels predict the higher risk of death, non-fatal myocardial infarction, and recurrent angina requiring repeat coronary angiography.  However, the prognosis is usually favorable as long as the patients are maintained on calcium channel blockers and risk factors such as smoking are addressed.

Pearls and Other Issues

Due to the heterogeneity of symptoms upon presentation, CAVS should be on a differential when a patient is presenting with symptoms. It is important to recognize CAVS when compared to obstructive atherosclerotic coronary artery disease due to different approaches to treatment. Furthermore, patients should be counseled to modify risk factors that can precipitate CAVS such as smoking, and treatment should be targeted in initiating and maintaining maximum tolerated doses of calcium channel blocker.  Due to patients having recurrent symptoms resulting from CAVS further research needs to be implemented to understand the pathogenesis and impact treatment options better.

Enhancing Healthcare Team Outcomes

Once a patient has been diagnosed with CAVS, the role of the primary and the nurse practitioner cannot be overstated. These professionals need to educate the patient on atherosclerosis and reduce the modifiable risk factors for coronary disease. Patients should be counseled to modify risk factors that can precipitate CAVS such as smoking, and treatment should be targeted in initiating and maintaining maximum tolerated doses of calcium channel blocker.  Due to patients having recurrent symptoms resulting from CAVS further research needs to be implemented to understand the pathogenesis and impact treatment options better. Close monitoring is required because recurrence of coronary vasospasm is common, which in some patients can prove fatal. (Level V)


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Coronary Artery Vasospasm - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following medications can induce vasospastic angina?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is not part of management of coronary spasm during percutaneous transluminal coronary angioplasty?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the typical presentation of coronary artery vasospasm?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the cornerstone of management of coronary artery vasospasm?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the definitive test to conform coronary artery vasospasm?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
In which age group is coronary artery vasospasm mostly prevalent?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Coronary Artery Vasospasm - References

References

Beijk MA,Vlastra WV,Delewi R,van de Hoef TP,Boekholdt SM,Sjauw KD,Piek JJ, Myocardial infarction with non-obstructive coronary arteries: a focus on vasospastic angina. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 2019 Jan 28;     [PubMed]
Cho SG,Kim Y,Jeong MH,Bom HS, Myocardial Infarction With Nonobstructive Coronary Arteries Assessed by 11C-Acetate Cardiac PET. Clinical nuclear medicine. 2019 Jan 18;     [PubMed]
Han SH,Lee KY,Her SH,Ahn Y,Park KH,Kim DS,Yang TH,Choi DJ,Suh JW,Kwon HM,Lee BK,Gwon HC,Rha SW,Jo SH,Ko KP,Baek SH, Impact of multi-vessel vasospastic angina on cardiovascular outcome. Atherosclerosis. 2018 Dec 23;     [PubMed]
Bertic M,Chue CD,Virani S,Davis MK,Ignaszewski A,Sedlak T, Coronary Vasospasm Following Heart Transplantation: Rapid Progression to Aggressive Cardiac Allograft Vasculopathy. The Canadian journal of cardiology. 2018 Dec;     [PubMed]
Teragawa H,Oshita C,Ueda T, Coronary spasm: It's common, but it's still unsolved. World journal of cardiology. 2018 Nov 26;     [PubMed]
Lim Y,Singh D,Loh PH,Poh KK, Multivessel coronary artery spasm in pericarditis. Singapore medical journal. 2018 Nov;     [PubMed]
Park SH,Choi BG,Rha SW,Kang TS, The multi-vessel and diffuse coronary spasm is a risk factor for persistent angina in patients received anti-angina medication. Medicine. 2018 Nov;     [PubMed]
Takeyoshi D,Kikuchi S,Miyake K,Tatsukawa T,Kobayashi D,Uchida D,Kitani Y,Kamiya H,Azuma N, Fatal Vasospasm of the Coronary Arteries in a Patient Undergoing Distal Bypass Surgery and Endovascular Therapy for Threatened Lower Limbs Due to Acute Exacerbation of Peripheral Arterial Disease. Annals of vascular diseases. 2018 Sep 25;     [PubMed]
Picard F,Sayah N,Spagnoli V,Adjedj J,Varenne O, Vasospastic angina: A literature review of current evidence. Archives of cardiovascular diseases. 2018 Sep 6;     [PubMed]
Benamer H,Millien V, [Coronary spasm a diagnostic and therapeutic challenge]. Presse medicale (Paris, France : 1983). 2018 Sep;     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of PA-Hospital Medicine. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for PA-Hospital Medicine, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in PA-Hospital Medicine, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of PA-Hospital Medicine. When it is time for the PA-Hospital Medicine board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study PA-Hospital Medicine.